The pilot clinical study will assess the correlation between fluid removal during dialysis and HemoCept device data.

Inclusion Criteria:

• Subject or representatives must have voluntarily signed the informed consent form before any study related procedures
• Subjects can be any gender, but must be between (and including) 18 and 75 years of age
• Subject has been on dialysis for more than 90 days and has been diagnosed with end stage kidney disease
• Subject is able and willing to provide informed consent and HIPAA authorization.
• Subject is able and willing to meet all study requirements
• Subject is able to place electrodes on bilateral deltoids and above the pant line on the waist.

Exclusion Criteria:

• Subject is pregnant, breast-feeding, or intends to become pregnant during the course of the study.
• Subject has a personal medical history that includes: Long Q-T syndrome, Cardiac channelopathies, genetic heart defects, Seizures, Acute untreated blood clotting disorders or acute untreated bleeding disorders
• Subject has had a heart transplant.

Subjects between (and including) the ages of 18 and 75 and who meet all the Inclusion/Exclusion criteria

There is not a plan to make IPD available